FRANCE –CardioRenal, a Grenoble-based company that specializes in improving the treatment of patients with severe chronic renal disease (CKD) at home, has raised US$3.7 million in seed funding. The backers…
Read MoreTag: Chronic Kidney disease
Kenya champions for early screening to improve detection of Chronic Kidney Disease
KENYA – Kenyatta National Hospital (KNH) has called for people to undergo early screening for chronic kidney disease (CKD) to allow implementation of therapeutic interventions which reduces the high mortality…
Read MoreLiberia achieves health milestone with launch of first National Dialysis Center
LIBERIA – Liberian President George Manneh Weah has commissioned a new National Dialysis Center with a 10-bed capacity in Monrovia to boost kidney disease treatment especially for patients with acute…
Read MoreBenevolentAI announces 3-year collaboration expansion with AstraZeneca
USA – BenevolentAI, a leading clinical-stage AI drug discovery company, has expanded its AI-driven drug discovery collaboration with AstraZeneca, doubling the number of disease areas under investigation. The three-year extension…
Read MoreFDA advisors slam Reata’s kidney disease drug
USA – An FDA advisory committee has delivered a crushing blow to Reata Pharma, voting unanimously that the drugmaker’s data on bardoxolone – a drug used to treat kidney disease…
Read MoreStanbic Bank donates dialysis machines to Zimbabwean hospital
ZIMBABWE – Kidney patients in Zimbabwe will benefit from a US$15 000 haemodialysis machine which has been donated to Gwanda Provincial Hospital by Stanbic Bank. The dialysis machine will assist…
Read MoreGSK’s anaemia drug Daprodustat delivers positive pre-clinical results
UNITED KINGDOM – GlaxoSmithKline Plc (GSK) has reported positive trial results for Daprodustat, a potential blockbuster anemia pill that the drugmaker hopes will bolster its pharma portfolio as it prepares…
Read MoreSurge in kidney ailments increases NHIF payment for renal dialysis
KENYA- Cost for covering renal dialysis has more than tripled over the last four years, as NHIF paid a whooping Ksh. 3.8 billion to cover dialysis expenses, indicating the growth…
Read MoreFDA approves Cara’s drug for severe itching in kidney disease patients
USA – The Food and Drug Administration has approved Cara Therapeutics’s drug to treat moderate-to-severe itching in patients with chronic kidney disease undergoing dialysis, making it the first therapy for…
Read MoreBayer’s Kerendia can now be used in USA as therapy for chronic kidney disease in type 2 diabetes patients
US – Bayer’s first-in-class nonsteroidal drug Kerendia is now available in the US for use following an approval as a therapy that can slow chronic kidney disease progression in patients…
Read More